Browse life science companies in Cambridge, home to one of Europe's leading biotechnology and life science ecosystems.
Somatic genomics for genetically validated drug target discovery
Quotient Therapeutics is a biotechnology company developing medicines from genetic differences between cells within the same person. Its somatic genomics platform combines sensitive DNA sequencing, cell analysis and computational biology to identify mutations linked to disease resistance or susceptibility. These…
AI-powered cell simulation platform targeting ageing and age-driven diseases
Shift Bioscience is a biotechnology company developing an AI-powered virtual cell platform to identify novel therapeutic targets for cellular rejuvenation. Its proprietary single-cell ageing clock measures epigenetic age at high throughput, feeding machine learning models that predict gene combinations and small…
Point-of-care molecular diagnostic platform for rapid infectious disease detection
Diagnostics for the Real World (Europe) is a Cambridge University spin-out developing and commercialising a fully automated point-of-care molecular diagnostic system for rapid detection of infectious diseases. Using isothermal nucleic acid amplification, the platform delivers sample-in-result-out testing without…
Synthetic VHH antibody libraries and discovery services
Isogenica is a contract discovery company specialising in VHH single-domain antibody discovery, offering what it describes as the world's largest synthetic VHH library alongside its proprietary screening platform. The company partners with pharmaceutical and biotechnology companies to identify high-affinity antibody…
Oral small-molecule therapies targeting autoimmune disease pathways
SMIN Therapeutics is a biotechnology company developing oral medicines for autoimmune diseases. Its drug discovery platform studies interactions between proteins to identify therapeutic compounds, with an initial focus on the neonatal Fc receptor (FcRn), which regulates immunoglobulin G (IgG). The company is…
AI-enabled small molecule drug discovery
PharmEnable is a Cambridge-based drug discovery company developing novel small molecule therapeutics for targets that are inaccessible to biologics, including intracellular targets and those behind the blood-brain barrier. Its proprietary platform integrates AI and advanced medicinal chemistry to explore undercharted…
Macrophage-based reprogramming of the innate immune system
Ojas Immune develops therapies that reprogramme macrophages, innate immune cells involved in inflammation, tissue repair and disease. Its platforms combine synthetic biology, stem cell engineering and computational modelling. SyntheMacs focuses on engineered macrophage cell therapies, while ReProMacs explores…
High-density e-textile sensors for AI-powered cardiac diagnostics
Polytecks is a University of Cambridge spin-out developing wearable, textile-based sensors for high-resolution bioelectrical mapping. Patented electrode arrays capture heart signals at far higher density than standard ECGs, with AI transforming the data into detailed cardiac maps within minutes to support earlier…
Breath biomarker research instruments and analytical services
Owlstone Medical Limited is a diagnostics company developing breath-based biomarker tools and laboratory services for clinical and life science research. Its sampling instruments collect exhaled breath for analysis of volatile organic compounds, which may reflect metabolic activity and disease processes. The company…
Fermentation-derived astaxanthin active ingredient for premium natural skincare
Kinva Bio is a UK-based fermentation biotechnology company developing bio-based active ingredients for the skincare industry. The company's first product is a fermentation-derived astaxanthin, a natural antioxidant positioned as a stronger and more scalable alternative to conventional algal-derived astaxanthin. Kinva…
Defined live bacterial consortia for oncology and inflammatory bowel disease
Microbiotica is a clinical-stage biopharmaceutical company developing oral live biotherapeutic products comprising defined consortia of gut commensal bacterial strains. Candidate bacterial strains are identified by analysing microbiome data from clinical outcome studies, enabling mechanistically grounded strain…
Distributor of antibodies and reagents for life science research
Stratech Scientific was a UK distributor of life science research products, including antibodies, reagents, cells and specialist laboratory supplies used in immunology, cell biology, cancer research and neuroscience. On 24 February 2026, Cambridge Bioscience acquired the business. Stratech's products and customer…
Reagents that stabilise and fix RNA, DNA and tissue samples
RNAssist is a reagents company developing patented stabilisation and fixation products for biological samples. Its formulations, based on deep eutectic solvents, preserve RNA, DNA, proteins and cell structure at the point of collection and are compatible with downstream methods such as single-cell sequencing and…
Biomarker-driven CRO integrating clinical trials and laboratory sciences
Precision for Medicine is a full-service contract research organisation built around biomarker-driven clinical development. The company integrates clinical trial execution with specialty laboratory services, translational science, data management, and biostatistics to support oncology, rare disease, and cell and gene…
Enzyme-free multiplex RNA diagnostics for rapid clinical decisions
Cambridge Nucleomics is a biotechnology company developing a proprietary nanopore-based platform for rapid, high-multiplexed detection of nucleic acid biomarkers. Its enzyme-free soluble nanoarray technology enables simultaneous quantification of up to 200 RNA and DNA targets from low-input samples within one hour.…
Global leader in next-generation sequencing and genomic analysis
Illumina is a US-headquartered life science company and the dominant provider of next-generation sequencing platforms and array-based genotyping tools. Its UK operations are based at Granta Park in Cambridge, serving as its primary European research and commercial hub. Illumina's technologies underpin applications in…
Microbial conversion of waste into sustainable aviation fuel feedstock
Neela Biotech develops microbial processes that convert food, agricultural and forestry waste into fatty acids for sustainable aviation fuel production. Its approach combines AI-guided microbes with anaerobic digestion and is designed to integrate into existing biogas plants rather than require entirely new…
Academic-industry translational research institute
The Milner Therapeutics Institute is a University of Cambridge biomedical research institute established to bridge academic science and pharmaceutical drug discovery. Founded in 2015 and based at the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus, it operates both an in-house research programme and…